Furosemide
Treatment for Alcoholic cardiomyopathy
Typical Dosage: 20-80mg daily
Effectiveness
60%
Safety Score
65%
Clinical Trials
100
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
65
DangerousModerateSafe
Treatment Details
Dosage Range
20-80mg daily
Time to Effect
immediate (hours)
Treatment Duration
as needed/lifetime
Evidence Quality
HIGHNumber Needed to Harm (NNH)
8(Treat 8 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$300
Side Effect Mgmt:$100
Total Annual:$450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$30,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$529
Comparison vs Placebo
Cost Difference
+$450/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
No dominance
Furosemide Outcomes
for Alcoholic cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+85%
Common Side Effects
Electrolyte imbalance (hypokalemia, hyponatremia)
+25%
Dizziness
+10%
Hypotension
+10%
Renal dysfunction
+5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov